| Literature DB >> 25631822 |
Jacob G Kirkland1, Misty R Peterson1, Christopher D Still1, Leo Brueggeman1, Namrita Dhillon1, Rohinton T Kamakaka2.
Abstract
Heterochromatin formation and nuclear organization are important in gene regulation and genome fidelity. Proteins involved in gene silencing localize to sites of damage and some DNA repair proteins localize to heterochromatin, but the biological importance of these correlations remains unclear. In this study, we examined the role of double-strand-break repair proteins in gene silencing and nuclear organization. We find that the ATM kinase Tel1 and the proteins Mre11 and Esc2 can silence a reporter gene dependent on the Sir, as well as on other repair proteins. Furthermore, these proteins aid in the localization of silenced domains to specific compartments in the nucleus. We identify two distinct mechanisms for repair protein-mediated silencing-via direct and indirect interactions with Sir proteins, as well as by tethering loci to the nuclear periphery. This study reveals previously unknown interactions between repair proteins and silencing proteins and suggests insights into the mechanism underlying genome integrity.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25631822 PMCID: PMC4454184 DOI: 10.1091/mbc.E14-09-1413
Source DB: PubMed Journal: Mol Biol Cell ISSN: 1059-1524 Impact factor: 4.138
FIGURE 1:(A) Schematic of the wild-type silenced locus. (B) Schematic of the modified locus used in this study and the mating assay when the Gal4 DNA–binding domain alone is expressed in the cell, resulting in no repression of the a1 gene. (C) Schematic of the modified locus used in this study and the mating assay when Gal4-Sir1 is expressed in the cell, resulting in silencing of the a1 gene.
FIGURE 2:Gal4-Mre11–mediated silencing. (A) Gal4-Mre11xmediated silencing in wild type and various mutant derivatives of this strain. Tenfold dilutions of MATα strains containing the modified HMR locus were spotted on a YMD-Trp plate (growth control) or a YMD plate containing an a lawn (JRY19a) to assay silencing. (B) Gal4-Mre11– and Gal4-Sir1–mediated silencing in a strain lacking Xrs2.
FIGURE 3:Gal4-Tel1–mediated silencing in wild-type and sir3Δ strains. Tethered silencing in the wild-type strain with a C-terminal truncation of Tel1 (Gal4-Tel1 CΔ).
FIGURE 4:Gal4-Tel1–mediated silencing. (A) Gal4-Tel1–mediated silencing in wild-type and various mutant derivatives of this strain. (B) Gal4-Tel1– and Gal4-Sir1–mediated silencing in a strain lacking Xrs2. (C) Gal4-Tel1–mediated silencing in a strain unable to phosphorylate H2A at serine 129.
FIGURE 5:ChIP mapping of γ-H2A at the modified HMR locus. ChIP was performed in a strain with the modified HMR locus expressing either the Gal4 DNA–binding domain alone or Gal4-Sir1, Gal4-Mre11, or Gal4-Tel1. Data are presented as the mean enrichment of IP/input further normalized to an ACT1 amplicon for four IPs from two independent cross-links. Error bars are SD from the mean.
FIGURE 6:Gal4-Esc2– and Gal4-Esc1–mediated silencing. (A) Gal4-Esc2–mediated silencing in wild type and various mutant derivatives of this strain. (B) Gal4-Esc2– and Gal4-Sir1–mediated silencing in wild type and a strain lacking Mph1. (C) Gal4-Esc1 mediated silencing in wild type and various mutant derivatives of this strain.
FIGURE 7:Silencing of ADE2 at the modified HMR locus by various fusion proteins.
FIGURE 8:Two-hybrid analysis of interactions between Sir proteins and repair proteins. (A) A wild-type strain was transformed with two different 2μ plasmids to coexpress Gal4-DBD fusions and Gal4-AD fusions. Growth on YMD plates lacking histidine was used to monitor interactions. (B) Two-hybrid analysis in strains lacking Sir proteins, using Gal4-Tel1 as bait.
FIGURE 9:Localization of the modified HMR locus in the yeast nucleus. A schematic of a yeast nucleus with two zones of equal surface area and a fluorescent locus are shown in the line diagram. (A–D) Graphs of the percentage of cells in each of the two zones in various strains. The data for Gal4 DNA–binding domain alone are shown simply for ease of comparison. ***p < 0.001 by χ2 test.
Plasmids used in this study.
| Plasmid | Description | Source |
|---|---|---|
| pRO1000 | Gal4 (1-147) 2μ URA3 | |
| pRO990 | Gal4-Tel1 CΔ 2μ URA3 | |
| pRO1022 | Gal4-AD-SIR4 2μ LEU2 | |
| GLC370 | Gal4-AD-SIR2 2μ LEU2 | D. Shore (University of Geneva) |
| PM875 | Gal4-AD-SIR3 2μ LEU2 | D. Shore |
| pRO998 | Gal4-AD-ESC2 2μ LEU2 | |
| pAct2.2 | Gal4-AD 2μ LEU2 | |
| pRO83 | Gal4-Sir1 2μ URA3 | |
| pRO963 | Gal4-Tel1 2μ URA3 | |
| pJR1112 | 2μ URA3 | |
| pRO1001 | Gal4-Mre11 2μ TRP1 | |
| pRO1003 | Gal4-Esc1 2μ TRP1 | |
| pRO1005 | Gal4-Sir1 2μ TRP1 | |
| pRO1044 | Gal4-Esc2 2μ TRP1 |
Strains used in this study.
| Strain | Description |
|---|---|
| ROY 5008 | |
| ROY 5010 | |
| ROY 5012 | |
| ROY 5014 | |
| ROY 5016 | |
| ROY 5018 | |
| ROY 5022 | |
| ROY 5026 | |
| ROY 5028 | |
| ROY 5030 | |
| ROY 5020 | |
| ROY 5024 | |
| ROY 5034 | |
| ROY 5036 | |
| ROY 5348 | |
| ROY 5349 | |
| ROY 5351* | |
| ROY 5378 | |
| ROY 5379 | |
| ROY 5380 | |
| ROY 5381 | |
| ROY 5382 | |
| ROY 5383 | |
| ROY 5384 | |
| ROY 5385 | |
| ROY 5386 | |
| ROY 5387 | |
| ROY 5388 | |
| ROY 5389 | |
| ROY 5390 | |
| ROY 5391 | |
| ROY 5392 | |
| ROY 5393 | |
| ROY 5394 | |
| ROY 5146* | |
| ROY 5324* | |
| ROY 5327* | |
| ROY 5332* | |
| ROY 5395 | |
| ROY 5396 | |
| ROY 5397 | |
| JRY19a | |
| JRY19@ |
*Not isogenic with W303.